In breast cancer models, deregulated activation of FAK promotes tumor progression and metastasis by affecting the cross-talk between cancer and stromal cells and by sensitizing tumor cells to ECM biochemical and mechano-signals, with profound effects on their genomic landscape [27]. The gene discussed is PTK2; the disease is neoplasm.